|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT02812849 |
|
Date of registration:
|
22/06/2016 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Somatostatin Receptor Imaging in Cardiac Sarcoidosis
|
|
Scientific title:
|
Somatostatin Receptor Imaging in Cardiac Sarcoidosis |
|
Date of first enrolment:
|
June 2016 |
|
Target sample size:
|
0 |
|
Recruitment status: |
Withdrawn |
|
URL:
|
https://clinicaltrials.gov/show/NCT02812849 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
Denmark
| | | | | | | |
|
Contacts
|
|
Name:
|
Rasmus S Ripa, MD, DMSc |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Rigshospitalet, Denmark |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
Group A: Suspected cardiac sarcoidosis Group B: Known cardiac sarcoidosis, clinical
follow-up Group C: Myocarditis or dilated cardiomyopathy (Non-cardiac sarcoidosis)
Exclusion Criteria:
Infection Pregnancy Severe claustrophobia Weight >140 kg
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Cardiac Sarcoidosis
|
|
Intervention(s)
|
|
Drug: Cu-64 DOTATATE
|
|
Primary Outcome(s)
|
|
Sensitivity to detect cardiac sarcoidosis
[Time Frame: 1 day at PET/CT examination]
|
|
Specificity to detect cardiac sarcoidosis
[Time Frame: 1 day at PET/CT examination]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|